What's happened
The film about Theranos founder Elizabeth Holmes has opened to a record North American documentary box office, with a restrained production opening on 855 screens and endorsements from critics and audiences alike. The documentary’s unconventional approach has sparked conversations about truth and accountability in biotech entrepreneurship.
What's behind the headline?
Analysis
- The film’s unusual format, placing Fielder inside Holmes’s world, is pushing audiences to reassess the ethics of reality-based entertainment.
- Its commercial success signals a growing appetite for character-driven investigations that tie personal narratives to national-level scrutiny of the biotech industry.
- The turnout on under-1000-screen releases challenges traditional documentary distribution models, suggesting a broader shift toward niche, high-impact storytelling.
- Expect ongoing debates about the line between journalism and entertainment as more audiences encounter this film’s approach.
How we got here
Nathan Fielder and Lance Oppenheim spent three years developing the film in secret, following Holmes and her family in the days before her federal prison sentence. The project has drawn attention for blending documentary with social experimentation and for its revelations about Holmes’s case and the Theranos saga.
Our analysis
BBC Business reports on the box-office and critical reception; The Guardian notes the film’s 855-screen opening and compares it to Fahrenheit 9/11; The Times and Associated Press coverage corroborate the production details and reception.
Go deeper
- Will this film influence public perception of Theranos further?
- Could this model alter how documentaries are funded and released?
- What does this imply for future investigations that blend journalism with reality-based entertainment?
More on these topics
-
Elizabeth Holmes - American biotechnology entrepreneur convicted of fraud
Elizabeth Anne Holmes (born February 3, 1984) is an American biotechnology entrepreneur who was convicted of fraud in connection with her blood-testing company, Theranos. The company's valuation soared after it claimed to have revolutionized blood testing
-
Nathan Fielder - Canadian writer
Nathan Joseph Fielder is a Canadian writer, comedian, actor, and entrepreneur. He is best known for co-creating and starring in the Comedy Central show Nathan for You.
-
11 - 2004 film
Fahrenheit 9/11 is a 2004 American documentary film directed, written by, and starring filmmaker, director and political commentator Michael Moore. The film takes a critical look at the presidency of George W. Bush, the war in Iraq, and its coverage in th
-
Lance Oppenheim - American filmmaker
Lance Oppenheim is an American filmmaker, documentarian, and producer from Fort Lauderdale, Florida. His work blends cinematic genres to explore the lives of people who create homes in unconventional spaces and places.
-
Theranos - Defunct American privately held health-technology company
Theranos Inc. () was an American privately held corporation that was touted as a breakthrough health technology company. Founded in 2003 by then 19-year-old Elizabeth Holmes, Theranos raised more than US$700 million from venture capitalists and private investors, resulting in a $9 billion valuation at its peak in 2013 and 2014. The company falsely claimed that it had devised blood tests that could be performed rapidly and accurately, while requiring very small amounts of blood, all using compact automated devices that the company had developed. A turning point came in 2015, when medical research professor John Ioannidis, and later, professor of clinical biochemistry Eleftherios Diamandis, along with investigative journalist John Carreyrou of The Wall Street Journal, questioned the validity of Theranos' technology. The company faced a string of legal and commercial challenges from medical authorities, investors, the U.S. Securities and Exchange Commission (SEC), the Centers for Medicare and Medicaid Services (CMS), state attorneys general, former business partners, patients, and others. By June 2016, Forbes estimated that Holmes's personal net worth had dropped from $4.5 billion to...